Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil solution safely and effectively treats hair loss.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Higher fluoride levels may delay puberty in boys.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

The nanoparticle-emulsion with polihexanide is more effective and lasts longer for skin antisepsis.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Honokiol helps protect skin from damage and aging caused by cigarette smoke.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.